KRAS and colorectal cancer: Proliferation and survival related signaling pathways such as PI3K/AKT/mTOR and RAS/RAF/MEK/ERK play important roles in pathogeneses of solid tumors [21], and KRAS, BRAF, and PIK3CA (PI3K) mutations are the most common in colorectal cancer [22].